AST 18th Annual Scientific Meeting

May 15-19, 1999 · Sheraton Hotel and Towers · Chicago, IL

Concurrent Session 38:
Intrathoracic: Candidate/Donor Selection and Management

Chairs: Adaani Frost and David Taylor


Return to the Agenda:

NOTE: You can search this page by using your browser's "Find" function
(under the "Edit" menu in Netscape Navigator/Communicator and Microsoft Internet Explorer)


2:00 #984 Can clinical outcome after partial left ventriculectomy be predicted?

G Bhat, R Dowling, MA Laureano and P Cerrito, Louisville, KY

2:10 #985 Lung volume reduction is of questionable benefit in a transplant population.

MD Iannettoni, MS Mulligan, LM Zaremba, JA Edwards, R Florn and MB Orringer, Ann Arbor, MI

2:20 #986 Predicting survival in urgent (status I) heart transplantation: a clinical prognostic model.

MR Mehra, PA Uber, D Dumas-Hicks, H deGruiter, CA Cassidy, L Orejarena, MH Park, RL Scott and CH Van Meter, New Orleans, LA

2:30 #987 Cardiowest total artificial heart as an excellent bridge to cardiac transplantation.

GM Mullen, K Malinowska, CE Lawless, BA Pisani, JC Mendez, JA Robinson, B Foy and M Bakhos, Maywood, IL

2:40 #988 Inhalation therapy with iloprost-trometadol may delay the need of LT/HLT in patients with pulmonary hypertension.

C Puelacher, C Geltner, H Jamnig and LC Müller, Innsbruck, Austria

2:50 #989 The impact of transplantation across a positive crossmatch and donor cause of death in heart transplantation.

ES Bishay, DJ Cook, H Abou El Fettouh, RC Starling, JB Young, NG Smedira and PM McCarthy, Cleveland, OH

3:00 #990 Long-term results of heart transplantation using donors over 63 years of age.

EV Potapov, M Loebe, M Hübler, S Heins, M Hummel, M Musci, Y Weng and H Hetzer, Berlin, Germany

3:10 #991 The national transplantation pregnancy registry: pregnancy in female lung transplant recipients.

S Cowan, L Coscia, C McGrory, J Mannion, L Ohler, W Gaughan, M Moritz and V Armenti, Philadelphia, PA

3:20 #992 Has extending donor criteria resulted in increased morbidity and mortality following cardiac transplantation?: a single center experience.

K Hoercher, JB Young, NS Smedira, J Navia, MK Banbury and PM McCarthy, Cleveland, OH

3:30 #993 Allograft substrate metabolism in clinical heart transplantation: effects of insulin (GIK) and amino acid infusion.

R Ekroth, A Shariari, A Bengtsson, U Kjellman, F Nilsson, G Svensson and L Wiklund, Göteborg, Sweden

3:40 #994 Glucose intolerance as reflected by hemoglobin A1C is significantly associated with a high incidence of transplant coronary artery disease.

T Kato, A Maehara, N Giannetti, S-Z Gao, SA Hunt and HA Valantine, Stanford, CA

Back to Top

Return to the Agenda

AST Home

Copyright ©1997-2000, AST
last revised: 10 April 1999

Site created by SLACK Incorporated
E-mail the Webmaster with questions or comments.